Bell D

No ORCID on file · 3 papers in corpus
article 2020
Effects of combined GnRH receptor antagonist linzagolix and hormonal add-back therapy on vaginal bleeding—delayed add-back onset does not improve bleeding pattern
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1007/s43032-020-00172-z

Linzagolix is a novel, oral GnRH receptor antagonist developed for the treatment of endometriosis and uterine fibroids. We assessed high-dose linzagolix safety and bleeding pattern effects in healthy women using combined versus delayed horm…

2014
2014 CUA Abstracts
Canadian Urological Association journal = Journal de l'Association des urologues du Canada
other 2000
Borderline tumors of the ovary: correlation of frozen and permanent histopathologic diagnosis
Obstetrics and gynecology ·doi:10.1016/s0029-7844(99)00656-0

OBJECTIVE: To evaluate the correlation between the diagnosis of borderline tumor of the ovary by frozen and permanent pathology. METHODS: All pathology reports with diagnoses of borderline tumor of the ovary between 1980 and 1998 at Massac…